| Literature DB >> 33113998 |
Melaine González García1, Armando Rodríguez2,3, Annia Alba4, Antonio A Vázquez4, Fidel E Morales Vicente5,6, Julio Pérez-Erviti1, Barbara Spellerberg7, Steffen Stenger7, Mark Grieshober7, Carina Conzelmann8, Jan Münch8, Heinz Raber9, Dennis Kubiczek9, Frank Rosenau9, Sebastian Wiese3, Ludger Ständker2, Anselmo Otero-González1.
Abstract
Antimicrobial peptides (AMPs) are biomolecules with antimicrobial activity against a broad group of pathogens. In the past few decades, AMPs have represented an important alternative for the treatment of infectious diseases. Their isolation from natural sources has been widely investigated. In this sense, mollusks are promising organisms for the identification of AMPs given that their immune system mainly relies on innate response. In this report, we characterized the peptide fraction of the Cuban freshwater snail Pomacea poeyana (Pilsbry, 1927) and identified 37 different peptides by nanoLC-ESI-MS-MS technology. From these peptide sequences, using bioinformatic prediction tools, we discovered two potential antimicrobial peptides named Pom-1 (KCAGSIAWAIGSGLFGGAKLIKIKKYIAELGGLQ) and Pom-2 (KEIERAGQRIRDAIISAAPAVETLAQAQKIIKGG). Database search revealed that Pom-1 is a fragment of Closticin 574 previously isolated from the bacteria Clostridium tyrobutyrium, and Pom-2 is a fragment of cecropin D-like peptide first isolated from Galleria mellonella hemolymph. These sequences were chemically synthesized and evaluated against different human pathogens. Interestingly, structural predictions of both peptides in the presence of micelles showed models that comprise two alpha helices joined by a short loop. The CD spectra analysis of Pom-1 and Pom-2 in water showed for both structures a high random coil content, a certain content of α-helix and a low β-sheet content. Like other described AMPs displaying a disordered structure in water, the peptides may adopt a helical conformation in presence of bacterial membranes. In antimicrobial assays, Pom-1 demonstrated high activity against the Gram-negative bacteria Pseudomonas aeruginosa and moderate activity against Klebsiella pneumoniae and Listeria monocytogenes. Neither of the two peptides showed antifungal action. Pom-1 moderately inhibits Zika Virus infection but slightly enhances HIV-1 infectivion in vitro. The evaluation of cell toxicity on primary human macrophages did not show toxicity on THP-1 cells, although slight overall toxicity was observed in high concentrations of Pom-1. We assume that both peptides may play a key role in innate defense of P. poeyana and represent promising antimicrobial candidates for humans.Entities:
Keywords: Pomacea poeyana; antibacterial activity; antimicrobial peptides
Year: 2020 PMID: 33113998 PMCID: PMC7690686 DOI: 10.3390/biom10111473
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1(A) Cartoon diagrams of the predicted structure for Pom-1 (left) and Pom-2 (right), modeled using QUARK and SwissModel servers (Manufacturer, City, State abbrev., if USA or Canada, Country), respectively. Residue side chains are represented in sticks. (B) Amino acid sequence of Pom-1 and Pom-2 models and its associated secondary structure. The gray boxes represent alpha helix residues; the black lines represent unordered residues. Hydrophobic residues are highlighted in red, hydrophilic residues in blue.
Structure evaluation of the six predicted models for Pom-1 and Pom-2.
| Model | MolProbity Score | Clash | Poor Rotamers | Favored Rotamers | Ramachandran Outliers | Ramachandran Favored | Cβ Deviations | Bad | Bad Angles |
|---|---|---|---|---|---|---|---|---|---|
| Pom-1_1 | 2.72 | 5.9 | 2/22 | 17/22 | 2/32 | 27/32 | 3/27 | 0/246 | 2/326 |
| Pom-1_2 | 3.1 | 7.8 | 7/22 | 14/22 | 2/32 | 29/32 | 1/27 | 0/246 | 0/326 |
| Pom-1_3 | 2.98 | 3.9 | 3/22 | 15/22 | 3/32 | 18/32 | 0/27 | 0/246 | 1/326 |
| Pom-1_4 | 2.86 | 2.0 | 7/22 | 11/22 | 2/32 | 25/32 | 1/27 | 0/246 | 3/326 |
| Pom-1_5 | 1.99 | 0.0 | 4/22 | 16/22 | 0/32 | 29/32 | 2/27 | 0/246 | 0/326 |
| Pom-2 | 1.41 | 0.0 | 2/24 | 21/24 | 1/30 | 29/30 | 1/31 | 0/245 | 0/328 |
Figure 2Helical wheel diagrams of N-terminal and C-terminal helix of Pom-1 (top) and Pom-2 (bottom). Hydrophobic residues are displayed in red, hydrophilic residues in blue. The arrow size is proportional to the hydrophobic moment and points to the hydrophobic side of the helix.
Figure 3Circular dichroism (CD) spectra of peptides Pom-1 (blue) and Pom-2 (red) at 30 µM concentration in H2O.
Secondary structure content of peptides Pom-1 and Pom-2 in H2O.
| Peptide | Helix (%) | Sheets (%) | Turns (%) | Random (%) |
|---|---|---|---|---|
| Pom-1 | 22.2 | 8.9 | 20.8 | 48.1 |
| Pom-2 | 21.0 | 2.8 | 21.7 | 54.5 |
Agar diffusion test of Gram-positive and Gram-negative bacterial species against Pomacea poeyana peptides.
| Bacterial Species | Pom-1 | Pom-2 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (µg/mL) | 5 | 10 | 20 | 30 | 40 | 50 | 5 | 10 | 20 | 30 | 40 | 50 |
| 0.4 | 0.55 | 0.65 | 0.7 | 0.8 | 0.85 | - | - | - | 0.2 | 0.2 | 0.45 | |
| 0.25 | 0.35 | 0.35 | 0.35 | 0.4 | 0.45 | - | - | - | 0.15 | 0.3 | 0.4 | |
| - | - | 0.3 | 0.3 | 0.4 | 0.43 | - | - | - | - | - | - | |
Figure 4Effect of Pom-1 on Zika virus (ZIKV) and Human immunodeficiency virus 1 (HIV-1) infection. (A) Vero E6 or TZMbl cells were treated with Pom-1 or water and infected with ZIKV MR766 or HIV-1 NL4-3, respectively. Two days later, infection rates were quantified using cell-based ZIKV immunodetection or β-galactosidase reporter assay. Values were corrected for the background signal derived from uninfected cells. (B) Vero E6 or TZMbl cells were treated with Pom-1 or water according to the infection protocol. Two days later, metabolic viability was assessed by MTT-based assay. Values of untreated controls were set to 100% viability. Data in (A,B) are normalized to values in the absence of the respective compound and represented as average values obtained from two independent experiment in triplicates ± standard deviations.
Values of the 50% cytotoxic concentration (CC50), half maximal inhibitory concentration (IC50) and selectivity index (SI).
| Virus | ZIKV (Vero E6) | HIV-1 (TZMb1) |
|---|---|---|
|
| 88.05 | 80.58 |
|
| 438.00 | 40.16 |
|
| 4.97 | 0.50 |
Figure 5Cytotoxic effects of P. poeyana peptides at 100 µg/mL on primary human macrophages. Experiments were performed in triplicates, and the results are shown as mean values. Standard deviation is shown as vertical bars.